Advertisement

Diuretics in Hypertension Therapy

  • James Sowers
  • Joel Neutel
  • Matthew Weir
Chapter
Part of the Current Clinical Practice book series (CCP)

Abstract

Diuretics have been and remain an important class of antihypertensive agents. They are a critical component of the hypertension therapeutic regimen, particularly for patients with systolic hypertension, the elderly, African Americans and diabetic patients. In large controlled clinical trials, diuretic therapy has consistently lowered morbidity and mortality for cardiovascular disease as well as stroke. For this reason, diuretic therapy is an important component of the overall antihypertensive regimen.

Keywords

Thiazide Diuretic Systolic Hypertension Diuretic Therapy Adverse Metabolic Effect European Working Party 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (1997) Arch Intern Med 157: 2413–2446.Google Scholar
  2. 2.
    SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265 (24): 3255–3264.Google Scholar
  3. 3.
    MRC Working Party (1992) Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 304 (6824): 405–412.CrossRefGoogle Scholar
  4. 4.
    Mac Mahanon S, Rodgers A (1993) The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hypertens 15 (6): 967–978.CrossRefGoogle Scholar
  5. 5.
    Neutel JM, Weir M, Sowers J (1996) Metabolic manifestations of low-dose diuretics. Am J Med 101 (Suppl.): 715–825.Google Scholar
  6. 6.
    Bakris GL, Weir MR, Sowers JR (1996) Therapeutic challenges in the obese diabetic patient with hypertension. Am J Med 101 (Suppl 3A): 33S - 46S.PubMedCrossRefGoogle Scholar
  7. 7.
    Neutel JM, Black HR, Weber MW (1996) Combination therapy with diuretics: An evolution of understanding. Am J Med l01 (suppl 3A): 61S - 70S.CrossRefGoogle Scholar
  8. 8.
    Jamerson K, DeQuattro V (1996) The impact of ethnicity on response to antihypertensive therapy. Am J Med 101 (Suppl 3A): 22S - 32S.PubMedCrossRefGoogle Scholar
  9. 9.
    Weir MR, Flack JM, Applegate WB (1996) Tolerability, safety, and quality of life and hypertensive therapy: The case for low-dose diuretics. Am J Med 101 (Suppl 3A): 83S - 92S.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • James Sowers
  • Joel Neutel
  • Matthew Weir

There are no affiliations available

Personalised recommendations